
Breaking News
Patient Experience Data is becoming regulatory-grade evidence and that changes everything
The pharmaceutical industry has spent years discussing patient centricity. But a new reflection paper from the European Medicines Agency (EMA) suggests something much more significant is happening: Patient experience data (PED) is evolving from supportive information into a structured component

